↓ Skip to main content

Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites

Overview of attention for article published in Frontiers in Pharmacology, May 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
Published in
Frontiers in Pharmacology, May 2019
DOI 10.3389/fphar.2019.00530
Pubmed ID
Authors

Zahra Khalaj, Zohreh Baratieh, Parvaneh Nikpour, Matthias Schwab, Elke Schaeffeler, Fariborz Mokarian, Hossein Khanahmad, Rasoul Salehi, Thomas E. Mürdter, Mansoor Salehi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 18%
Student > Master 4 10%
Lecturer 3 8%
Student > Ph. D. Student 3 8%
Student > Doctoral Student 2 5%
Other 4 10%
Unknown 17 43%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 12 30%
Biochemistry, Genetics and Molecular Biology 4 10%
Medicine and Dentistry 3 8%
Agricultural and Biological Sciences 1 3%
Unknown 20 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2019.
All research outputs
#20,572,330
of 23,149,216 outputs
Outputs from Frontiers in Pharmacology
#10,376
of 16,539 outputs
Outputs of similar age
#298,280
of 349,964 outputs
Outputs of similar age from Frontiers in Pharmacology
#289
of 351 outputs
Altmetric has tracked 23,149,216 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,539 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,964 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 351 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.